Work

Predose and Postdose Forced Expiratory Flow Between 25% and 75% (FEF25-75%) in Adolescents and Adults With Asthma Treated With Twice-Daily Budesonide/Formoterol Pressurized Metered-Dose Inhaler (BUD/FM pMDI) or BUD pMDI for 1 Year

Year: 2009

Type: article

Study design: Clinical Trial

Source: Journal of Allergy and Clinical Immunology

DOI: 10.1016/j.jaci.2008.12.274

Authors: J. Zangrilli, J. McElhattan, C.D. O'Brien, J. Baker

Institution: AstraZeneca (United States)

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2169446996

FWCI:

Cites:

Cited by:

Related to: 10